Jeremy Davis - Feb 21, 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role: SVP Chief Commercial Officer
Signature: /s/ Jeremy Davis
Stock symbol: LAB
Transactions as of: Feb 21, 2023
Transactions value $: -$12,537
Form type: 4
Date filed: 2/23/2023, 08:45 PM
Previous filing: Jan 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LAB	Common Stock	Options Exercise	$0	+20.8K		$0.00	20.8K	Feb 21, 2023	Direct
transaction	LAB	Common Stock	Tax liability	-$12.5K	-6.18K	-29.65%	$2.03	14.7K	Feb 21, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LAB	Restricted Stock Units	Options Exercise	$0	-20.8K	-8.33%	$0.00	229K	Feb 21, 2023	Common Stock	20.8K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2	On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.